Prakash K, Dutta S
WHO Collaborating Centre for Reference and Training in Streptococcal Diseases, Department of Microbiology, Lady Hardinge Medical College, New Delhi, India.
J Med Microbiol. 1991 Feb;34(2):119-24. doi: 10.1099/00222615-34-2-119.
Antibody to at least one type of streptococcal opacity factor (OF) was present in 39.0% of 235 selected subjects and, in 47.8% of these, to more than one type. Only 21.6% of children less than 4 years old had antibody to OF; these were to one type in 62.5% or to more than one in 37.5%. In the study group as a whole, the commonest antibodies were those to OF from M-serotype 25 followed, in descending order, by serotypes 4, 22, 2, 9, 48, 49, 28, 61 and 75. Patients with rheumatic fever or rheumatic heart disease most often had antibodies to OF from M-types 25, 22, 4 and 9, whereas in patients with acute glomerulonephritis, antibodies to OF from M-types 48, 49 and 61 were commonest. The limitations of the OF-inhibition test as an epidemiological marker for prevalent M-types of group A streptococci are discussed.
在235名选定的受试者中,39.0%的人存在针对至少一种链球菌表面蛋白(OF)的抗体,其中47.8%的人存在针对不止一种类型的抗体。4岁以下儿童中只有21.6%有针对OF的抗体;其中62.5%针对一种类型,37.5%针对不止一种类型。在整个研究组中,最常见的抗体是针对M血清型25的OF抗体,其次按降序排列为血清型4、22、2、9、48、49、28、61和75。风湿热或风湿性心脏病患者最常具有针对M型25、22、4和9的OF抗体,而在急性肾小球肾炎患者中,针对M型48、49和61的OF抗体最为常见。本文讨论了OF抑制试验作为A组链球菌流行M型的流行病学标志物的局限性。